# Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

> **NCT02232113** · PHASE4 · COMPLETED · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 67 (actual)

## Conditions studied

- Anemia
- Inflammation
- Malnutrition

## Interventions

- **DRUG:** CERA

## Key facts

- **NCT ID:** NCT02232113
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2014-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02232113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02232113, "Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02232113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*